These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25889041)

  • 1. Wanted: prospective studies of alternative donors.
    Brunstein CG
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):957-8. PubMed ID: 25889041
    [No Abstract]   [Full Text] [Related]  

  • 2. Low usage rate of banked sibling cord blood units in hematopoietic stem cell transplantation for children with hematological malignancies: implications for directed cord blood banking policies.
    Goussetis E; Peristeri I; Kitra V; Papassavas AC; Theodosaki M; Petrakou E; Spiropoulos A; Paisiou A; Soldatou A; Stavropoulos-Giokas C; Graphakos S
    Blood Cells Mol Dis; 2011 Feb; 46(2):177-81. PubMed ID: 21095146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
    Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
    J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
    Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?
    Ruggeri A; Ciceri F; Gluckman E; Labopin M; Rocha V;
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):207-16. PubMed ID: 20837332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical donor transplants in ALL.
    Das M
    Lancet Oncol; 2017 Sep; 18(9):e516. PubMed ID: 28781170
    [No Abstract]   [Full Text] [Related]  

  • 7. Haematopoietic transplants combining a single unrelated cord blood unit and mobilized haematopoietic stem cells from an adult HLA-mismatched third party donor. Comparable results to transplants from HLA-identical related donors in adults with acute leukaemia and myelodysplastic syndromes.
    Sebrango A; Vicuña I; de Laiglesia A; Millán I; Bautista G; Martín-Donaire T; Regidor C; Cabrera R; Fernandez MN
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):259-74. PubMed ID: 20837338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors.
    Cairo MS; Rocha V; Gluckman E; Hale G; Wagner J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):44-53. PubMed ID: 18162220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selection of an unrelated donor for hematopoietic stem cell transplantation. HLA haplotypes in patients with blood system diseases].
    Khamaganova EG; Parovichnikova EN; Kuz'mina LA; Gemdzhian ÉG; Chugreeva TP; Iushkova AA
    Ter Arkh; 2014; 86(7):31-6. PubMed ID: 25314775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for alternative hematopoietic stem cell donors for pediatric patients.
    Rocha V; Locatelli F
    Bone Marrow Transplant; 2008 Jan; 41(2):207-14. PubMed ID: 18084331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematopoietic Stem Cell Transplantation using unrelated cord blood: which unit to choose? A report of the SFGM-TC].
    Michel G; Detrait M; Elsermans V; Faucher C; Hicheri Y; Ivanova-Derin R; Lemarie C; Sirvent A; Top I; Garnier F; Boulanger F; Michallet M; Yakoub-Agha I;
    Pathol Biol (Paris); 2013 Aug; 61(4):147-8. PubMed ID: 24011969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor selection process for allogeneic hematopoietic stem cell transplantation at the university hospital of Düsseldorf (1997-1998).
    Enczmann J; Rinker M; Kiesel U; Kuhröber A; Kögler G; Nürnberger W; Göbel U; Wernet P
    Klin Padiatr; 1999; 211(4):218-23. PubMed ID: 10472554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
    El-Cheikh J; Crocchiolo R; Furst S; Bramanti S; Sarina B; Granata A; Vai A; Lemarie C; Faucher C; Mohty B; Harbi S; Bouabdallah R; Vey N; Santoro A; Chabannon C; Castagna L; Blaise D
    Cancer; 2015 Jun; 121(11):1809-16. PubMed ID: 25649994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies.
    Krishnamurti L; Abel S; Maiers M; Flesch S
    Bone Marrow Transplant; 2003 Apr; 31(7):547-50. PubMed ID: 12692619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease.
    Justus D; Perez-Albuerne E; Dioguardi J; Jacobsohn D; Abraham A
    Pediatr Blood Cancer; 2015 Jul; 62(7):1285-7. PubMed ID: 25663074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia.
    Atsuta Y; Morishima Y; Suzuki R; Nagamura-Inoue T; Taniguchi S; Takahashi S; Kai S; Sakamaki H; Kouzai Y; Kobayashi N; Fukuda T; Azuma H; Takanashi M; Mori T; Tsuchida M; Kawase T; Kawa K; Kodera Y; Kato S;
    Biol Blood Marrow Transplant; 2012 May; 18(5):780-7. PubMed ID: 22008851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
    Finke J; Schmoor C; Bethge WA; Ottinger HD; Stelljes M; Zander AR; Volin L; Heim DA; Schwerdtfeger R; Kolbe K; Mayer J; Maertens JA; Linkesch W; Holler E; Koza V; Bornhäuser M; Einsele H; Bertz H; Grishina O; Socié G;
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1716-26. PubMed ID: 22713691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
    Willemze R; Ruggeri A; Purtill D; Rodrigues CA; Gluckman E; Rocha V;
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):283-90. PubMed ID: 20837340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
    Ayas M; Al-Seraihi A; El-Solh H; Al-Ahmari A; Khairy A; Aldali A; Markiz S; Siddiqui K; Al-Jefri A
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):627-32. PubMed ID: 21871862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.